Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
2.
Res Pract Thromb Haemost ; 8(4): 102421, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38827255

RESUMEN

Background: Overuse of antiplatelet therapy and underuse of gastroprotection contribute to preventable bleeding in patients taking anticoagulants. Objectives: (1) Determine the feasibility of a factorial trial testing patient activation and clinician outreach to reduce gastrointestinal (GI) bleeding risk in patients prescribed warfarin-antiplatelet therapy without proton pump inhibitor gastroprotection and (2) assess intervention acceptability. Methods: Pragmatic 2 × 2 factorial cluster-randomized controlled pilot comparing (1) a patient activation booklet vs usual care and (2) clinician notification vs clinician notification plus nurse facilitation was performed. The primary feasibility outcome was percentage of patients completing a structured telephone assessment after 5 weeks. Exploratory outcomes, including effectiveness, were evaluated using chart review, surveys, and semistructured interviews. Results: Among 47 eligible patients, 35/47 (74.5%; 95% CI, 58.6%-85.7%) met the feasibility outcome. In the subset confirmed to be high risk for upper GI bleeding, 11/29 (37.9%; 95% CI, 16.9%-64.7%) made a medication change, without differences between intervention arms. In interviews, few patients reported reviewing the activation booklet; barriers included underestimating GI bleeding risk, misunderstanding the booklet's purpose, and receiving excessive health communication materials. Clinicians responded to notification messages for 24/47 patients (51.1%; 95% CI, 26.4%-75.4%), which was lower for surgeons than nonsurgeons (22.7% vs 76.0%). Medical specialists but not surgeons viewed clinician notification as acceptable. Conclusion: The proposed trial design and outcome ascertainment strategy were feasible, but the patient activation intervention is unlikely to be effective as designed. While clinician notification appears promising, it may not be acceptable to surgeons, findings which support further refinement and testing of a clinician notification intervention.

3.
Narrat Inq Bioeth ; 12(3): 227-233, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-38661811

RESUMEN

These stories of fetal death make us aware of the several losses that attend a miscarriage and-equally important-they highlight the personal, cultural, and organizational constraints that make difficult the kind of caring responses needed to address these losses. In reading these narratives, we feel the grief and frustration caused by the inappropriate, or absent, reactions of caregivers. The seeming meaninglessness of the event led some to look for meaning in religion, while for others, the loss challenged their understandings of God. These stories also point to the importance of rituals-religious or otherwise-for helping the bereaved "carry their sorrow." Careful listening to the experiences of these women can help us make the changes-organizational and personal-that are necessary to provide the care and comfort those living through a miscarriage need.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA